Self-proning and Repositioning in COVID-19 Outpatients at Risk of Complicated Illness
NCT ID: NCT05518474
Last Updated: 2023-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
11 participants
INTERVENTIONAL
2021-10-15
2023-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Effects of Awake Prone Positioning in COVID-19 ICU Patients
NCT06080737
A Virtual Ward to Reduce Readmissions After Hospital Discharge
NCT01108172
A Clinical Pathway for Nursing Home Acquired Pneumonia
NCT00157612
Support for COVID19 Patients at Home
NCT04898179
Automatic Stop Orders for Urinary Catheters
NCT00157625
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Self-proning
Participants assigned to the intervention arm will receive a SMS link to a PDF containing instructions on proning/repositioning and information about its physiological benefits. They'll also receive a PDF with standard recommendations for treating COVID-19 at home. Participants will be encouraged to lie flat on their belly, on their side, or sit upright and rotate between these positions when lying down during the day and night. Participants will be sent a daily SMS "proning reminder" and asked to complete a secure REDCap survey regarding their proning activity. They'll be advised to prone and reposition for seven days minimum whenever they are lying down. Participants who have failed to reach their functional baseline after this time period will be advised to continue doing so. Follow up assessment by telephone will be conducted in 7 day increments from baseline up to 28 days.
Self-proning
Rotating between lying flat with the chest down, on one's side or sitting up every 30 minutes to 2 hours when lying down during the day or while sleeping at night.
Standard care
Participants assigned to the comparator arm will receive a SMS link to a PDF with standard recommendations for treating COVID-19 at home. This includes antipyretics and analgesics for fever, myalgias, and headaches; hydration; and rest with advancement of activity as soon as tolerated. Follow up assessment by telephone will be conducted in 7 day increments from baseline up to 28 days.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-proning
Rotating between lying flat with the chest down, on one's side or sitting up every 30 minutes to 2 hours when lying down during the day or while sleeping at night.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Positive SARS-CoV-2 PCR test
3. Presence of two or more of the following criteria:
1. Age\>55 years
2. Fever by history or at presentation
3. Cough
4. Dyspnea/shortness of breath
5. Fatigue necessitating daytime bed rest
6. One or more of the following medical conditions:
* Hypertension
* Diabetes
* Cardiovascular disease
* Chronic lung disease
* Chronic kidney disease
* Obesity (BMI≥30kg/m2)
7. Tachycardia \> 110 bpm
8. Oxygen saturation \<94%
9. One or more of the following laboratory abnormalities:
* Lymphocytes \<1500/microL
* ESR \> 100 mm/h
* CRP \> 10 mg/L
* D-Dimer \> 1000 ng/mL
* LDH \> 240 U/L
10. Bilateral infiltrates or ground glass opacities on chest x-ray or CT scan
4. Socially and medically fit for discharge
5. Access to a smartphone
Exclusion Criteria
2. Body mass index (BMI) \>40 kg/m2.
3. Skeletal deformities that interfere with proning
4. Developmental delay or cognitive impairment that would preclude patient cooperation
5. Other contraindications to proning including any of the following: recent abdominal surgery, active vomiting, acute intoxication.
6. Unlikely to adhere to the proning protocol according to the treating physician's judgment
7. Fully vaccinated for COVID-19
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Applied Health Research Centre
OTHER
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Joseph's Health Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
homeproningpilot_21_069
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.